Recalcitrant Nongenital Warts
Overview
Authors
Affiliations
Nongenital warts are a common presentation in general practice. Despite treatment according to evidence based guidelines, a significant proportion of common warts fail to resolve, becoming recalcitrant. This poses a problem in clinical management. The recommendations for treating recalcitrant warts are unclear and there is a wide range of second line treatments available. This article reviews the available methods of treatment for recalcitrant nongenital warts as described in the medical literature.
Human papillomavirus vaccination for recalcitrant cutaneous warts.
Karofylakis E, Gkrania-Klotsas E, Kumararatne D IJID Reg. 2024; 13:100488.
PMID: 39691354 PMC: 11650136. DOI: 10.1016/j.ijregi.2024.100488.
Biglari S, Moghaddam A, Tabatabaiefar M, Sherkat R, Youssefian L, Saeidian A Genet Med. 2023; 26(2):101028.
PMID: 37978863 PMC: 10922824. DOI: 10.1016/j.gim.2023.101028.
HPV-Related Skin Phenotypes in Patients with Inborn Errors of Immunity.
El Kettani A, Ailal F, El Bakkouri J, Zerouali K, Beziat V, Jouanguy E Pathogens. 2022; 11(8).
PMID: 36014978 PMC: 9414374. DOI: 10.3390/pathogens11080857.
Zampella J, Cohen B Skin Health Dis. 2022; 2(1):e98.
PMID: 35665206 PMC: 9060099. DOI: 10.1002/ski2.98.
Al-Qassabi A, Al Kindi A Oman Med J. 2022; 37(2):e353.
PMID: 35356369 PMC: 8941530. DOI: 10.5001/omj.2022.01.